DA

David R. Anderson

AT Aclaris Therapeutics: 2 patents #1 of 13Top 8%
CT Cadent Therapeutics: 2 patents #1 of 8Top 15%
NA Novartis Ag: 2 patents #18 of 378Top 5%
Pfizer: 1 patents #71 of 301Top 25%
📍 Salem, CT: #1 of 10 inventorsTop 10%
🗺 Connecticut: #101 of 3,623 inventorsTop 3%
Overall (2023): #17,425 of 537,848Top 4%
7
Patents 2023

Issued Patents 2023

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDate
11820775 Pyrrolopyrimidine ITK inhibitors Eric Jon Jacobsen, James Robert Blinn, Susan L. Hockerman, Richard Heier, Paramita Mukherjee 2023-11-21
11807650 NMDA receptor modulators and uses thereof Robert A. Volkmann, Frank S. Menniti, Christopher Fanger, Yuelian Xu 2023-11-07
11739086 Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same Susan L. Hockerman, James Robert Blinn, Eric Jon Jacobsen 2023-08-29
11702424 Bicyclic-fused heteroaryl or aryl compounds John David Trzupek, Katherine Lin Lee, Mark Edward Bunnage, Seungil Han, David Hepworth +18 more 2023-07-18
11648253 Thienopyrimidinone NMDA receptor modulators and uses thereof Robert A. Volkmann, Frank S. Menniti, Christopher Fanger 2023-05-16
11541057 Thienopyrimidinone NMDA receptor modulators and uses thereof Robert A. Volkmann, Frank S. Menniti, Christopher Fanger 2023-01-03
11542264 Heteroaromatic NMDA receptor modulators and uses thereof Robert A. Volkmann, Gregg F. Keaney, Steven C. Leiser, Sam Malekiani, Timothy Piser 2023-01-03